Your browser doesn't support javascript.
loading
Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha.
Ranges, G E; Figari, I S; Espevik, T; Palladino, M A.
Affiliation
  • Ranges GE; Department of Molecular Immunology, Genentech, Inc., South San Francisco, California 94080.
J Exp Med ; 166(4): 991-8, 1987 Oct 01.
Article in En | MEDLINE | ID: mdl-3498791
ABSTRACT
The immunoregulatory effects of transforming growth factor beta (TGF-beta) and recombinant murine tumor necrosis factor alpha (rMuTNF-alpha) on CTL generation and activity were examined. The results demonstrate that TGF-beta, in a dose-dependent manner, inhibited CTL generation but not CTL activity. The inhibitory effects were detected only when TGF-beta was added within the first 48 h of the MLC. Little activity was seen when it was added thereafter, including the addition of TGF-beta to the cytotoxicity assay. The production of TNF-alpha, which occurs during early phases of the MLC and which is inhibited in the presence of TGF-beta, appears to have an important regulatory role, as altering the levels of TNF-alpha in an MLC can significantly influence CTL development. The inhibitory effects of TGF-beta on the MLC can be significantly reversed by the addition of rMuTNF-alpha to the cultures. These results demonstrate that TGF-beta can inhibit MLC and subsequent CTL generation at early stages of the reaction, and such inhibition may involve the suppression of TNF-alpha production.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Recombinant Proteins / T-Lymphocytes, Cytotoxic / Tumor Necrosis Factor-alpha Limits: Animals Language: En Journal: J Exp Med Year: 1987 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Recombinant Proteins / T-Lymphocytes, Cytotoxic / Tumor Necrosis Factor-alpha Limits: Animals Language: En Journal: J Exp Med Year: 1987 Type: Article